Patents by Inventor J. Futrell

J. Futrell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9596994
    Abstract: A system including a medical instrument, a sensor, and a processor module in communication with the sensor. The medical instrument includes a radiation source for transmitting electromagnetic radiation from within a body and through a material in the body. The sensor receives a portion of the electromagnetic radiation transmitted through the material, and the processor module determines at least one characteristic of the material based on the electromagnetic radiation received by the sensor.
    Type: Grant
    Filed: June 4, 2007
    Date of Patent: March 21, 2017
    Inventors: J. William J. Futrell, David J. Gaskin
  • Patent number: 8894067
    Abstract: A board game is provided having the theme Death and Taxes. Multiple levels of paths of spaces are indicated on a board, each level having differing rules affecting the amount of scrip currency that a player receives or loses in playing. Players' pieces are moved to differing levels dependent on the amount of currency assigned to that player (Net Worth).
    Type: Grant
    Filed: June 10, 2008
    Date of Patent: November 25, 2014
    Inventors: Henley W. Futrell, III, Bobbie J. Futrell
  • Publication number: 20090302538
    Abstract: A board game is provided having the theme Death and Taxes. Multiple levels of paths of spaces are indicated on a board, each level having differing rules affecting the amount of scrip currency that a player receives or loses in playing. Players' pieces are moved to differing levels dependent on the amount of currency assigned to that player (Net Worth).
    Type: Application
    Filed: June 10, 2008
    Publication date: December 10, 2009
    Inventors: Henley W. Futrell, III, Bobbie J. Futrell
  • Publication number: 20050282275
    Abstract: The present invention provides adipose-derived stem cells and lattices. In one aspect, the present invention provides a lipo-derived stem cell substantially free of adipocytes and red blood cells and clonal populations of connective tissue stem cells. The invention also provides a method of isolating stem cells from adipose tissues. The cells can be employed, alone or within biologically-compatible compositions, to generate differentiated tissues and structures, both in vivo and in vitro. Additionally, the cells can be expanded and cultured to produce hormones and to provide conditioned culture media for supporting the growth and expansion of other cell populations. In another aspect, the present invention provides a lipo-derived lattice substantially devoid of cells, which includes extracellular matrix material from adipose tissue. The lattice can be used as a substrate to facilitate the growth and differentiation of cells, whether in vivo or in vitro, into anlagen or even mature tissues or structures.
    Type: Application
    Filed: August 24, 2005
    Publication date: December 22, 2005
    Applicants: University of Pittsburgh of the Commonwealth System of Higher Education, The Regents of the University of California
    Inventors: Adam Katz, Ramon Llull, J. Futrell, Marc Hedrick, Prosper Benhaim, Hermann Lorenz, Min Zhu
  • Publication number: 20050153442
    Abstract: The present invention provides adipose-derived stem cells (ADSCs), adipose-derived stem cell-enriched fractions (ADSC-EF) and adipose-derived lattices, alone and combined with the ADSCs of the invention. In one aspect, the present invention provides an ADSC substantially free of adipocytes and red blood cells and clonal populations of connective tissue stem cells. The ADSCs can be employed, alone or within biologically-compatible compositions, to generate differentiated tissues and structures, both in vivo and in vitro. Additionally, the ADSCs can be expanded and cultured to produce molecules such as hormones, and to provide conditioned culture media for supporting the growth and expansion of other cell populations. In another aspect, the present invention provides a adipose-derived lattice substantially devoid of cells, which includes extracellular matrix material from adipose tissue.
    Type: Application
    Filed: May 12, 2004
    Publication date: July 14, 2005
    Inventors: Adam Katz, Ramon Llull, J. Futrell, Marc Hedrick, Prosper Benhaim, Hermann Lorenz, Min Zhu, Patricia Zuk, Peter Ashjian
  • Publication number: 20050153441
    Abstract: The present invention provides adipose-derived stem cells (ADSCs), adipose-derived stem cell-enriched fractions (ADSC-EF) and adipose-derived lattices, alone and combined with the ADSCs of the invention. In one aspect, the present invention provides an ADSC substantially free of adipocytes and red blood cells and clonal populations of connective tissue stem cells. The ADSCs can be employed, alone or within biologically-compatible compositions, to generate differentiated tissues and structures, both in vivo and in vitro. Additionally, the ADSCs can be expanded and cultured to produce molecules such as hormones, and to provide conditioned culture media for supporting the growth and expansion of other cell populations. In another aspect, the present invention provides a adipose-derived lattice substantially devoid of cells, which includes extracellular matrix material from adipose tissue.
    Type: Application
    Filed: December 17, 2003
    Publication date: July 14, 2005
    Inventors: Marc Hedrick, Adam Katz, Ramon Llull, J. Futrell, Prosper Benhaim, Hermann Lorenz, Min Zhu
  • Publication number: 20050076396
    Abstract: The present invention provides adipose-derived stem cells (ADSCs), adipose-derived stem cell-enriched fractions (ADSC-EF) and adipose-derived lattices, alone and combined with the ADSCs of the invention. In one aspect, the present invention provides an ADSC substantially free of adipocytes and red blood cells and clonal populations of connective tissue stem cells. The ADSCs can be employed, alone or within biologically-compatible compositions, to generate differentiated tissues and structures, both in vivo and in vitro. Additionally, the ADSCs can be expanded and cultured to produce molecules such as hormones, and to provide conditioned culture media for supporting the growth and expansion of other cell populations. In another aspect, the present invention provides a adipose-derived lattice substantially devoid of cells, which includes extracellular matrix material from adipose tissue.
    Type: Application
    Filed: August 29, 2003
    Publication date: April 7, 2005
    Inventors: Adam Katz, Ramon Llull, J. Futrell, Marc Hedrick, Prosper Benhaim, Hermann Lorenz, Min Zhu, Patricia Zuk, Peter Ashjian
  • Patent number: 6777231
    Abstract: The present invention provides adipose-derived stem cells and lattices. In one aspect, the present invention provides a lipo-derived stem cell substantially free of adipocytes and red blood cells and clonal populations of connective tissue stem cells. The cells can be employed, alone or within biologically-compatible compositions, to generate differentiated tissues and structures, both in vivo and in vitro. Additionally, the cells can be expanded and cultured to produce hormones and to provide conditioned culture media for supporting the growth and expansion of other cell populations. In another aspect, the present invention provides a lipo-derived lattice substantially devoid of cells, which includes extracellular matrix material from adipose tissue. The lattice can be used as a substrate to facilitate the growth and differentiation of cells, whether in vivo or in vitro, into anlagen or even mature tissues or structures.
    Type: Grant
    Filed: September 10, 2001
    Date of Patent: August 17, 2004
    Assignee: The Regents of the University of California
    Inventors: Adam J. Katz, Ramon Llull, William J. Futrell, Marc H. Hedrick, Prosper Benhaim, Hermann Peter Lorenz, Min Zhu